These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29525822)

  • 1. Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial.
    Berwanger O; Nicolau JC; Carvalho AC; Jiang L; Goodman SG; Nicholls SJ; Parkhomenko A; Averkov O; Tajer C; Malaga G; Saraiva JFK; Fonseca FA; De Luca FA; Guimaraes HP; de Barros E Silva PGM; Damiani LP; Paisani DM; Lasagno CMR; Candido CT; Valeis N; Moia DDF; Piegas LS; Granger CB; White HD; Lopes RD;
    JAMA Cardiol; 2018 May; 3(5):391-399. PubMed ID: 29525822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trial.
    Berwanger O; Nicolau JC; Carvalho AC; Jiang L; Goodman S; Nicholls SJ; Parkhomenko A; Averkov O; Tajer C; Malaga G; Kerr Saraiva JF; Fonseca F; Guimaraes HP; de Barros E Silva PGM; Damiani LP; Paisani DM; Lasagno CMR; Candido CT; Valeis N; Moia DDF; Piegas LS; Granger CB; White H; Lopes RD
    Am Heart J; 2018 Aug; 202():89-96. PubMed ID: 29908420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial.
    Berwanger O; Lopes RD; Moia DDF; Fonseca FA; Jiang L; Goodman SG; Nicholls SJ; Parkhomenko A; Averkov O; Tajer C; Malaga G; Saraiva JFK; Guimaraes HP; de Barros E Silva PGM; Damiani LP; Santos RHN; Paisani DM; Miranda TA; Valeis N; Piegas LS; Granger CB; White HD; Nicolau JC
    J Am Coll Cardiol; 2019 Jun; 73(22):2819-2828. PubMed ID: 30898608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial.
    Park DW; Kwon O; Jang JS; Yun SC; Park H; Kang DY; Ahn JM; Lee PH; Lee SW; Park SW; Choi SW; Lee SG; Yoon HJ; Ahn T; Kim MH; Nah DY; Lee SY; Chae JK; Park SJ;
    Circulation; 2019 Dec; 140(23):1865-1877. PubMed ID: 31553203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.
    Gimbel M; Qaderdan K; Willemsen L; Hermanides R; Bergmeijer T; de Vrey E; Heestermans T; Tjon Joe Gin M; Waalewijn R; Hofma S; den Hartog F; Jukema W; von Birgelen C; Voskuil M; Kelder J; Deneer V; Ten Berg J
    Lancet; 2020 Apr; 395(10233):1374-1381. PubMed ID: 32334703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Barbarawi M; Zayed Y; Hicks M; Ahmed S; Bachuwa G; Hassan M; Bhatt DL
    J Thromb Thrombolysis; 2018 Oct; 46(3):299-303. PubMed ID: 29934940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial.
    Kim CJ; Park MW; Kim MC; Choo EH; Hwang BH; Lee KY; Choi YS; Kim HY; Yoo KD; Jeon DS; Shin ES; Jeong YH; Seung KB; Jeong MH; Yim HW; Ahn Y; Chang K;
    Lancet; 2021 Oct; 398(10308):1305-1316. PubMed ID: 34627490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health.
    Ahn JH; Ahn Y; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Hwang JY; Yoon JH; Seong IW; Hur SH; Oh SK;
    J Cardiol; 2020 May; 75(5):478-484. PubMed ID: 31859138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
    Pereira NL; Farkouh ME; So D; Lennon R; Geller N; Mathew V; Bell M; Bae JH; Jeong MH; Chavez I; Gordon P; Abbott JD; Cagin C; Baudhuin L; Fu YP; Goodman SG; Hasan A; Iturriaga E; Lerman A; Sidhu M; Tanguay JF; Wang L; Weinshilboum R; Welsh R; Rosenberg Y; Bailey K; Rihal C
    JAMA; 2020 Aug; 324(8):761-771. PubMed ID: 32840598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk.
    Park KH; Jeong MH; Kim HK; Ki YJ; Kim SS; Choi DH; Koh YY; Ahn Y; Kim HS; Gwon HC; Rha SW; Hwang JY;
    J Korean Med Sci; 2021 Nov; 36(42):e268. PubMed ID: 34725976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor versus clopidogrel in patients with acute coronary syndromes.
    Wallentin L; Becker RC; Budaj A; Cannon CP; Emanuelsson H; Held C; Horrow J; Husted S; James S; Katus H; Mahaffey KW; Scirica BM; Skene A; Steg PG; Storey RF; Harrington RA; ; Freij A; Thorsén M
    N Engl J Med; 2009 Sep; 361(11):1045-57. PubMed ID: 19717846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial.
    Watanabe H; Morimoto T; Natsuaki M; Yamamoto K; Obayashi Y; Ogita M; Suwa S; Isawa T; Domei T; Yamaji K; Tatsushima S; Watanabe H; Ohya M; Tokuyama H; Tada T; Sakamoto H; Mori H; Suzuki H; Nishikura T; Wakabayashi K; Hibi K; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Morino Y; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
    JAMA Cardiol; 2022 Apr; 7(4):407-417. PubMed ID: 35234821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis.
    Venetsanos D; Sederholm Lawesson S; Alfredsson J; Janzon M; Cequier A; Chettibi M; Goodman SG; Van't Hof AW; Montalescot G; Swahn E
    BMJ Open; 2017 Sep; 7(9):e015241. PubMed ID: 28939567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST-Segment-Elevation Myocardial Infarctions.
    Schmucker J; Fach A; Mata Marin LA; Retzlaff T; Osteresch R; Kollhorst B; Hambrecht R; Pohlabeln H; Wienbergen H
    J Am Heart Assoc; 2019 Sep; 8(18):e012530. PubMed ID: 31538856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Antiplatelet Therapy De-Escalation in Stabilized Myocardial Infarction With High Ischemic Risk: Post Hoc Analysis of the TALOS-AMI Randomized Clinical Trial.
    Lee M; Byun S; Lim S; Choo EH; Lee KY; Moon D; Choi IJ; Hwang BH; Kim CJ; Park MW; Choi YS; Kim HY; Yoo KD; Jeon DS; Yim HW; Chang K;
    JAMA Cardiol; 2024 Feb; 9(2):125-133. PubMed ID: 38117483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Triple Therapy With Ticagrelor or Prasugrel Versus Clopidogrel After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    Gill K; Servati N; Flahive J; Fraielli K
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):625-629. PubMed ID: 34236915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Aytekin A; Ndrepepa G; Neumann FJ; Menichelli M; Mayer K; Wöhrle J; Bernlochner I; Lahu S; Richardt G; Witzenbichler B; Sibbing D; Cassese S; Angiolillo DJ; Valina C; Kufner S; Liebetrau C; Hamm CW; Xhepa E; Hapfelmeier A; Sager HB; Wustrow I; Joner M; Trenk D; Fusaro M; Laugwitz KL; Schunkert H; Schüpke S; Kastrati A
    Circulation; 2020 Dec; 142(24):2329-2337. PubMed ID: 33115278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y
    JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Ticagrelor vs. Clopidogrel in East Asian Patients with Acute Myocardial Infarction: A Nationwide Cohort Study.
    Chang CJ; Tung YC; Liu JR; Chang SH; Kuo CT; See LC
    Clin Pharmacol Ther; 2021 Feb; 109(2):443-451. PubMed ID: 32767756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.